UKBi015-A-8

iLB-C16bm-s6 non-edit BAG3 E5

General

Cell Line

hPSCreg name UKBi015-A-8
Cite as:
UKBi015-A-8
Alternative name(s)
iLB-C16bm-s6 non-edit BAG3 E5
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines No similar lines found.
Last update 19th August 2024
Notes This cell line is an internal experimental control for the gene edited subclones UKBi015-A-6 and UKBi015-A-7. UKBi015-A-8 underwent the same experimental procedure without actual genetic modification of the BAG3 gene.
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator Universitätsklinikum Bonn (UKB)
Owner Institute of Physiology I
Distributors
Derivation country Germany

External Databases

BioSamples SAMEA115753257

General Information

* Is the cell line readily obtainable for third parties?
No
Subclone of

Donor Information

General Donor Information

Sex male
Ethnicity caucasian

Phenotype and Disease related information (Donor)

Diseases No disease was diagnosed.

Donor Relations

Other cell lines of this donor

External Databases (Donor)

BioSamples SAMEA7222555

Ethics

Also have a look at the ethics information for the parental line UKBi015-A .
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General

The source cell information can be found in the parental cell line UKBi015-A.

Reprogramming method

Vector type Non-integrating
Vector Sendai virus
Genes
Is reprogramming vector detectable?
No
Methods used
PCR
Vector map

Vector free reprogramming

Other

Derived under xeno-free conditions
Unknown
Derived under GMP?
Unknown
Available as clinical grade?
Unknown

Culture Conditions

Medium Other medium:
Base medium: StemMACS iPS Brew XF Medium
Main protein source:
Serum concentration: %
Supplements
StemMACS iPS Brew XF 50x Supplement 10 ml

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
SSEA-1
Yes
POU5F1 (OCT-4)
Yes
TRA 1-60
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro directed differentiation
Mesoderm
Ont Id: UBERON_0000926
In vitro directed differentiation
Ectoderm
Ont Id: UBERON_0000924
In vitro directed differentiation

Microbiology / Virus Screening

HIV 1 Negative
HIV 2 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46, XY
Passage number: p10
Karyotyping method: Molecular karyotyping by SNP array
http://

Other Genotyping (Cell Line)

Genetic Modification

Disease/phenotype related modifications
This cell line is an internal experimental control for the gene edited subclones UKBi015-A-6 and UKBi015-A-7. UKBi015-A-8 underwent the same experimental procedure without actual genetic modification of the BAG3 gene.
Synonyms
  • BAG3 myofibrillar myopathy (disease)
  • myofibrillar myopathy (disease) caused by mutation in BAG3
  • myofibrillar myopathy 6
  • myofibrillar myopathy type 6
  • myopathy, myofibrillar, type 6
  • BAG3-related myofibrillar myopathy
  • MFM6
  • muscular dystrophy, Selcen type
  • myopathy, myofibrillar, 6
  • myopathy, myofibrillar, Bag3-related
show more synonyms
Genetic modifications not related to a disease
Isogenic modification
This cell line is an internal experimental control for the gene edited subclones UKBi015-A-6 and UKBi015-A-7. UKBi015-A-8 underwent the same experimental procedure without actual genetic modification of the BAG3 gene.